Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ScarTec Therapeutics Logo
ScarTec Therapeutics Growth Score
68
CB Rank
210881
Heat Score
49
ScarTec Therapeutics develops novel peptide-based technology for scar-free healing.
Founded
obfuscation
PrivateGrant Enschede, Overijssel, The Netherlands1-10 scartec-therapeutics.com/
Biotechnology
Medical
Overview

ScarTec Therapeutics
Total Funding
obfuscation
Growth Score
68
Heat Score
49

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score68
-4 pts
in past quarter
Heat Score 49
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ScarTec Therapeutics

CB Rank
210881
ScarTec Therapeutics develops novel peptide-based technology for scar-free healing.
Founded
obfuscation
PrivateGrant Enschede, Overijssel, The Netherlands1-10 scartec-therapeutics.com/
Biotechnology
Medical

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name ScarTec Therapeutics BV
Operating Status Active
Company Type For Profit
Founders  Jai Prakash
About the Company
ScarTec Therapeutics develops novel peptide-based technology for scar-free healing.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Proprietary Platform for Identifying Novel Targets
A platform developed to identify new targets that can stop the activation of cancer-associated fibroblasts (CAFs).
Strategies to Detect and Reverse Tumor Fibrosis
Approaches aimed at detecting and reversing fibrosis in tumors to improve T-cell infiltration and drug access to cancer cells.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
1
obfuscation
— Grant
obfuscation
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
1
obfuscation
— Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
EISMEA Logo
EISMEA
—
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
—
EISMEA Logo
EISMEA
—
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
—
EISMEA Logo
EISMEA
—
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
—
EISMEA Logo
EISMEA
—
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
—
EISMEA Logo
EISMEA
—
Grant - ScarTec Therapeutics Logo
Grant - ScarTec Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1

Employee Profiles

News
Technology
View Tech Report

IT Spend

$302.8KThis year, ScarTec Therapeutics is projected to spend $302.8K on IT, according to Aberdeen.

Active Website Tech Count

8ScarTec Therapeutics is actively using 8 technologies for its website, according to BuiltWith. These include SPF, U.S. Server Location, and  Amazon.
Sub-Organizations
Frequently Asked Questions

Where is ScarTec Therapeutics's headquarters? ScarTec Therapeutics is located in Enschede, Overijssel, The Netherlands.Who invested in ScarTec Therapeutics? ScarTec Therapeutics is funded by EISMEA.When was the last funding round for ScarTec Therapeutics? ScarTec Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are ScarTec Therapeutics's competitors? Alternatives and possible competitors to ScarTec Therapeutics may include FibroBiologics, MolecuLight, and  Medical University of South Carolina.How much funding has ScarTec Therapeutics raised to date? ScarTec Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|